CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities:
Net income	$ 1,448,000,000	$ 1,606,000,000
Less: Net income attributable to the noncontrolling interest	21,000,000	25,000,000
Net income attributable to Honeywell	1,427,000,000	1,581,000,000
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities:
Depreciation	171,000,000	153,000,000
Amortization	170,000,000	90,000,000
Gain on sale of non-strategic businesses and assets	(90,000,000)	0
Repositioning and other charges	141,000,000	62,000,000
Net payments for repositioning and other charges	(195,000,000)	(111,000,000)
Pension and other postretirement income	(293,000,000)	(212,000,000)
Pension and other postretirement benefit payments	(14,000,000)	(14,000,000)
Stock compensation expense	77,000,000	44,000,000
Deferred income taxes	63,000,000	(58,000,000)
Other	(96,000,000)	(179,000,000)
Changes in assets and liabilities, net of the effects of acquisitions and divestitures:
Accounts receivable	143,000,000	41,000,000
Inventories	(158,000,000)	(163,000,000)
Other current assets	(66,000,000)	166,000,000
Accounts payable	57,000,000	(54,000,000)
Accrued liabilities	(359,000,000)	(407,000,000)
Net cash provided by (used for) operating activities	978,000,000	939,000,000
Cash flows from investing activities:
Expenditures for property, plant and equipment	(221,000,000)	(139,000,000)
Proceeds from disposals of property, plant and equipment	14,000,000	7,000,000
Increase in investments	(736,000,000)	(648,000,000)
Decrease in investments	612,000,000	843,000,000
Receipts (payments) from settlements of derivative contracts	140,000,000	287,000,000
Cash paid for acquisitions, net of cash acquired	(1,303,000,000)	0
Proceeds from sales of businesses, net of fees paid	190,000,000	0
Net cash provided by (used for) investing activities	(1,304,000,000)	350,000,000
Cash flows from financing activities:
Proceeds from issuance of commercial paper and other short-term borrowings	1,268,000,000	3,455,000,000
Payments of commercial paper and other short-term borrowings	(1,266,000,000)	(3,373,000,000)
Proceeds from issuance of common stock	67,000,000	66,000,000
Proceeds from issuance of long-term debt	23,000,000	1,127,000,000
Payments of long-term debt	(817,000,000)	(1,125,000,000)
Repurchases of common stock	(822,000,000)	(1,923,000,000)
Cash dividends paid	(640,000,000)	(635,000,000)
Other	(30,000,000)	(38,000,000)
Net cash provided by (used for) financing activities	(2,217,000,000)	(2,446,000,000)
Effect of foreign exchange rate changes on cash and cash equivalents	(14,000,000)	(189,000,000)
Net increase (decrease) in cash and cash equivalents	(2,557,000,000)	(1,346,000,000)
Cash and cash equivalents at beginning of period	14,275,000,000	9,067,000,000
Cash and cash equivalents at end of period	$ 11,718,000,000	$ 7,721,000,000